🇺🇸 FDA
Patent

US 9290572

Integrin α-Vβ8 neutralizing antibody

granted A61KA61K2039/505A61P

Quick answer

US patent 9290572 (Integrin α-Vβ8 neutralizing antibody) held by The Regents of the University of California expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61P, A61P1/16, A61P11/00